References
Cook PF, Schmiege SJ, Mansberger S, Kammer J, Fitzgerald T, Kahook MY. Predictors of adherence to glaucoma treatment in a multi-site study. Ann Behav Med. 2015. doi:10.1007/s12160-014-9641-8.
Friedman DS, Jampel H, Congdon N, et al. The TRAVATAN Dosing Aid accurately records when drops are taken. Am J Ophthalmol. 2007; 143: 699-701.
Sleath B, Blalock SJ, Covert D, et al. Patient race, reported problems in using glaucoma medications, and adherence. ISRN Ophthalmol. 2012; 2012: 902819.
Okeke CO, Quigley HA, Jampel HD, et al. Adherence with topical glaucoma medication monitored electronically: The Travatan Dosing Aid study. Ophthalmology. 2009; 116: 191-199.
Friedman DS, Quigley HA, Gelb L, et al. Using pharmacy claims data to study adherence to glaucoma medications: Methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). Invest Ophthalmol Vis Sci. 2007; 48: 5052-5057.
Robin AL, Novack GD, Covert DW, et al. Adherence in glaucoma: Objective measurements of once-daily and adjunctive medication use. Am J Ophthalmol. 2007; 144: 533-540.
Lee BL, Gutierrez P, Gordon M, et al. The glaucoma symptom scale. A brief index of glaucoma-specific symptoms. Arch Ophthalmol. 1998; 116(7): 861-866.
Okeke CO, Quigley HA, Jampel HD, et al. Interventions improve poor adherence with once daily glaucoma medications in electronically monitored glaucoma patients. Ophthalmology. 2009; 116: 2286-2293.
Boland MV, Chang DS, Frazier T, et al. Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: The Automated Dosing Reminder Study. JAMA Ophthalmol. 2014. doi:10.1001/jamaophthalmol.2014.856.
Cate H, Bhattacharya D, Clark A, et al. Improving adherence to glaucoma medication: A randomised controlled trial of a patient-centred intervention (The Norwich Adherence Glaucoma Study). BMC Ophthalmol. 2014; 14: 32. doi:10.1186/1471-2415-14-32.
Chang DS, Friedman DS, Frazier T, et al. Development and validation of a predictive model for nonadherence with once-daily glaucoma medications. Ophthalmology. 2013; 120: 1396-1402.
Gurwitz JH, Glynn RJ, Monane M, et al. Treatment for glaucoma: Adherence by the elderly. Am J Public Health. 1993; 83: 711-716.
Kosoko O, Quigley HA, Vitale S, et al. Risk factors for non-compliance with glaucoma follow-up visits. Ophthalmology. 1998; 105: 2105-2111.
Conflict of Interest
Author Harry Quigley declares that he has no conflict of interest. He is a consultant for three companies that make ophthalmic products or drugs (Zeiss, AC Immune, Sensimed) and is on the scientific advisory board of Graybug, Inc.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Quigley, H.A. Reminder Systems, Not Education, Improve Glaucoma Adherence: a Comment on Cook et al.. ann. behav. med. 49, 5–6 (2015). https://doi.org/10.1007/s12160-014-9644-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12160-014-9644-5